Elestrin™ (transdermal estradiol gel) is a new gel formulation of bioidentical estradiol developed by BioSante Pharmaceuticals, Inc. (IL, USA). In Elestrin, estradiol is carried in a patent-pending ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the initiation of sales and marketing activity of Elestrin (estradiol gel) by Azur Pharma, BioSante’s ...

SAN ANTONIO, May 29, 2014 /PRNewswire/ --Mission Pharmacal Company has begun exclusive promotion of Elestrin® (estradiol gel) 0.06% in the United States through an agreement with Meda AB. Elestrin is ...

Bradley Pharmaceuticals Announces FDA Approval Of Elestrin (estradiol gel 0.06%) FAIRFIELD, N.J., Dec. 19 -- Bradley Pharmaceuticals, Inc. announced today that the Company has been notified by ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that it has reacquired Elestrin (estradiol gel) from Nycomed US who in February 2008 acquired Bradley ...

Antares Pharma, Inc announced that the company received a milestone payment of $450,000 from BioSante Pharmaceuticals, Inc related to an agreement with Azur Pharma for the marketing of Elestrin ...

Estradiol 0.06%; gel; contains alcohol. The addition of exogenous estrogens, such as Elestrin, helps to alleviate the vasomotor symptoms associated with declining estrogen levels. Elestrin contains ...

SAN ANTONIO — Mission Pharmacal on Thursday announced that it has begun the promotion of Elestrin (estradiol gel) 0.06% in the United States through an agreement with Meda AB. The drug is a used as a ...

EWING, N.J. Antares Pharma has received an additional payment of $875,000 from BioSante Pharmaceuticals in relation to a marketing agreement with Bradley Pharmaceuticals for the drug Elestrin.

Biosante Pharmaceuticals said the Food and Drug Administration approved its Bio-E-Gel, which treats hot flashes associated with menopause. Shares of Biosante jumped on the American Stock Exchange. The ...

*T max shown as median (range). More than two-thirds of women experience hot flashes during menopause, and approximately 25% of women during perimenopause and in the first years after menopause ...